tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see NMRA full AI Analyst Report?

Neumora Therapeutics, Inc. (NMRA) Financial Statements

414 Followers

Neumora Therapeutics, Inc. Financial Overview

Neumora Therapeutics, Inc.'s market cap is currently $445.76M. The company's EPS TTM is $-1.45; its P/E ratio is -1.23; Neumora Therapeutics, Inc. is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -5.00M$ 0.00$ -668.00K$ 0.00$ 0.00
Operating Income$ -241.16M$ -263.46M$ -188.19M$ -135.87M$ -237.32M
EBITDA$ -233.37M$ -262.83M$ -187.53M$ -135.28M$ -236.78M
Net Income$ -236.93M$ -243.79M$ -235.93M$ -130.90M$ -237.31M
Balance Sheet
Cash & Short-Term Investments$ 182.53M$ 307.58M$ 453.98M$ 371.88M$ 409.25M
Total Assets$ 191.05M$ 316.97M$ 496.19M$ 426.23M$ 429.30M
Total Debt$ 477.00K$ 1.85M$ 5.23M$ 8.44M$ 2.05M
Net Debt$ -182.05M$ -140.29M$ -368.81M$ -232.50M$ -407.19M
Total Liabilities$ 87.18M$ 29.91M$ 27.12M$ 873.08M$ 754.52M
Stockholders' Equity$ 103.87M$ 287.06M$ 469.08M$ -446.85M$ -325.22M
Cash Flow
Free Cash Flow$ -206.44M$ -182.94M$ -163.40M$ -115.41M$ -76.24M
Operating Cash Flow$ -206.44M$ -182.94M$ -163.28M$ -114.90M$ -75.42M
Investing Cash Flow$ 168.52M$ -70.56M$ 64.39M$ -168.01M$ -817.00K
Financing Cash Flow$ 77.09M$ 21.60M$ 231.94M$ 115.74M$ 293.51M
Currency in USD

Neumora Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Neumora Therapeutics, Inc. Debt to Assets

Balance Sheet >

Neumora Therapeutics, Inc. Cash Flow

Cash Flow >

Neumora Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >